These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3671460)

  • 1. The influence of propranolol and glucagon on the pharmacokinetics of antipyrine and sodium salicylate.
    Orszulak-Michalak D; Kaszubski P
    Pharmazie; 1987 Jun; 42(6):394-6. PubMed ID: 3671460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of glucagon infusion on the absorption of salicylic acid and antipyrine from the gastrointestinal tract].
    Káldor A; Bor K; Csillag K; Fenyvesi A; Gachályi B; Róna K; Vereczkey L
    Orv Hetil; 1988 Nov; 129(48):2577-9. PubMed ID: 3200588
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic drug interactions.
    Nies AS; Shand DG; Branch RA
    Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug interactions with misoprostol: effects on the pharmacokinetics of antipyrine and propranolol.
    Bennett PN; Fenn GC; Notarianni LJ
    Postgrad Med J; 1988; 64 Suppl 1():21-4. PubMed ID: 3138681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of estrogens on pharmacokinetics of phenazone and N-acetyl-p-aminophenol].
    Kwiatkowski A
    Ann Acad Med Stetin; 1991; 37():35-47. PubMed ID: 1816754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the evaluation of blood supply and mass of the liver for predicting the rate of pharmacokinetics of lidocaine, propranolol and phenazone].
    Hartleb M; Kloc T; Mańczyk I; Becker A; Bołdys H
    Pol Arch Med Wewn; 1989 Jun; 81(6):321-9. PubMed ID: 2634249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.
    Branch RA; Shand DG; Nies AS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):581-7. PubMed ID: 4203721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetic characteristics of drug substance in liver denervation].
    Ashirmetov AKh; Krakovskiĭ ME
    Farmakol Toksikol; 1989; 52(1):77-80. PubMed ID: 2707429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and protein binding of salicylate metabolites in rats.
    Morris ME
    Drug Metab Dispos; 1990; 18(5):809-11. PubMed ID: 1981740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasoactive action of glucagon on the portal system: II. Study of the hepatic vascular bed in dogs].
    de Miguel E; Ginestal JM; Salgado G; Veiga JL
    Rev Esp Enferm Apar Dig; 1981 Oct; 60(4):357-66. PubMed ID: 7330405
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: The influence of glucagon on regional blood flow in the rhesus monkey.
    Branch RA; Nies AS; Shand DG
    Br J Pharmacol; 1973 Sep; 49(1):149P. PubMed ID: 4207042
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse.
    Powis G; Snow DH
    J Pharmacol Exp Ther; 1978 Jun; 205(3):725-31. PubMed ID: 660540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of some anti-cancer drugs and combined chemotherapy on the pharmacokinetics of antipyrine in the rat.
    Skretkowicz J
    Pol J Pharmacol; 1995; 47(6):519-24. PubMed ID: 8868374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions with propranolol.
    Wood AJ; Feely J
    Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL; Varma DR
    Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.